0
Your cart

Your cart is empty

Books > Medicine > Other branches of medicine > Psychiatry

Buy Now

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (Paperback) Loot Price: R1,438
Discovery Miles 14 380
The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder...

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (Paperback)

American Psychiatric Association

 (sign in to rate)
Loot Price R1,438 Discovery Miles 14 380 | Repayment Terms: R135 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Donate to Against Period Poverty

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.

General

Imprint: American Psychiatric Publishing Inc
Country of origin: United States
Release date: March 2018
Authors: American Psychiatric Association
Dimensions: 279 x 213mm (L x W)
Format: Paperback - Trade
Pages: 224
ISBN-13: 978-0-89042-682-1
Categories: Books > Medicine > Other branches of medicine > Psychiatry
Books > Medicine > Other branches of medicine > Pharmacology > General
LSN: 0-89042-682-1
Barcode: 9780890426821

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners